<description>Dr. Steve Adelman, founder of MedPEP and director of the physician health 
program in Massachusetts, has a frank discussion with Marie and Les about 
physicians’ use of addictive substances like alcohol and marijuana. In this 
era of stress, burnout, and medical “battle fatigue,” doctors may be 
especially susceptible to numbing themselves with substances that have the 
potential to impede their performance. Steve’s perspective is that 
physicians are safety-sensitive professionals who are responsible for the 
health of the public. Consequently, they have an ethical obligation to stay 
above reproach by avoiding problematic use of psychoactive substances. 
Physicians with a history of problematic substance use should abstain; 
others should consider practices like “clean margin drinking,” a 
minimalistic approach that is fleshed out with specifics. Marie 
acknowledges that sometimes physicians cross the line in the name of 
celebration or stress relief. Steve points out that physicians are at risk 
because they have easy access to controlled substances and may also resist 
seeking professional help despite needing it. Marie and Steve discuss a 
specific case involving a patient whose therapist appeared impaired during 
a psychotherapy session. A guiding principle is that the safety of the 
public should never be compromised. Les asks Steve to comment on the use of 
marijuana by physicians. Steve focuses on the downside, advising licensed 
health professionals to avoid marijuana altogether. He links this MedPEP 
episode to earlier podcasts by suggesting that health professionals should 
avoid misusing substances; instead, we should focus on improving our 
self-care with diet, exercise, meditation, and better work/life balance, 
all of which may counter personal and professional burnout, and preserve 
our careers.</description>

MedPEP

PHS - Physician Health Services

Episode 17: Looking for Relief in the Wrong Places — Steve Adelman, MD

SEP 4, 2018-1 MIN
MedPEP

Episode 17: Looking for Relief in the Wrong Places — Steve Adelman, MD

SEP 4, 2018-1 MIN

Description

Dr. Steve Adelman, founder of MedPEP and the former medical director of the physician health program in Massachusetts, has a frank discussion with Marie and Les about physicians’ use of addictive substances like alcohol and marijuana. In this era of stress, burnout, and medical “battle fatigue,” doctors may be especially susceptible to numbing themselves with substances that have the potential to impede their performance. Steve’s perspective is that physicians are safety-sensitive professionals who are responsible for the health of the public. Consequently, they have an ethical obligation to stay above reproach by avoiding problematic use of psychoactive substances. Physicians with a history of problematic substance use should abstain; others should consider practices like “clean margin drinking,” a minimalistic approach that is fleshed out with specifics. Marie acknowledges that sometimes physicians cross the line in the name of celebration or stress relief. Steve points out that physicians are at risk because they have easy access to controlled substances and may also resist seeking professional help despite needing it. Marie and Steve discuss a specific case involving a patient whose therapist appeared impaired during a psychotherapy session. A guiding principle is that the safety of the public should never be compromised. Les asks Steve to comment on the use of marijuana by physicians. Steve focuses on the downside, advising licensed health professionals to avoid marijuana altogether. He links this MedPEP episode to earlier podcasts by suggesting that health professionals should avoid misusing substances; instead, we should focus on improving our self-care with diet, exercise, meditation, and better work/life balance, all of which may counter personal and professional burnout, and preserve our careers.Disclosure InformationNone of the individuals in a position to control the content of this CME activity, and/or their spouse/partner, have any relevant financial relationships with commercial interests to disclose.